Cargando…

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice

Disrupted neonatal lung angiogenesis and alveologenesis often give rise to bronchopulmonary dysplasia (BPD), the most common chronic lung disease in children. Hyperoxia-induced pulmonary vascular and alveolar damage in premature infants is one of the most common and frequent factors contributing to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Yanrong, Chen, Hongbin, Deng, Junchao, Ning, Junjie, Yang, Pengbo, Qiao, Lina, Cao, Zhongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716472/ https://www.ncbi.nlm.nih.gov/pubmed/36467073 http://dx.doi.org/10.3389/fphar.2022.1039103

Ejemplares similares

Claudin-18 expression under hyperoxia in neonatal lungs of bronchopulmonary dysplasia model rats
por: Zuo, Jingye, et al.
Publicado: (2022)

Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1
por: Hu, Yu, et al.
Publicado: (2019)

Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia
por: Li, Zhongying, et al.
Publicado: (2020)

Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
por: Giusto, Kiersten, et al.
Publicado: (2021)

Effects of Hyperoxia on Mitochondrial Homeostasis: Are Mitochondria the Hub for Bronchopulmonary Dysplasia?
por: Xuefei, Yu, et al.
Publicado: (2021)

Association of a FGFR-4 Gene Polymorphism with Bronchopulmonary Dysplasia and Neonatal Respiratory Distress
por: Rezvani, Milad, et al.
Publicado: (2013)

Vitamin D and IL-10 Deficiency in Preterm Neonates With Bronchopulmonary Dysplasia
por: Mao, Xiaonan, et al.
Publicado: (2018)

Endothelial Adenosine Monophosphate-Activated Protein Kinase-Alpha1 Deficiency Potentiates Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Elsaie, Ahmed, et al.
Publicado: (2021)

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
por: Iyengar, Anjali, et al.
Publicado: (2015)

METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy
por: Xu, Lili, et al.
Publicado: (2023)

Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
por: Endesfelder, Stefanie, et al.
Publicado: (2019)

S-endoglin expression is induced in hyperoxia and contributes to altered pulmonary angiogenesis in bronchopulmonary dysplasia development
por: Lee, Yeongseok, et al.
Publicado: (2020)

Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia
por: Natarajan, Viswanathan, et al.
Publicado: (2017)

Landscape analysis for a neonatal disease progression model of bronchopulmonary dysplasia: Leveraging clinical trial experience and real-world data
por: Barrett, Jeffrey S., et al.
Publicado: (2022)

MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia
por: Dong, Jie, et al.
Publicado: (2012)

Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia
por: Zhu, Yuting, et al.
Publicado: (2015)

Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia
por: Li, Chun, et al.
Publicado: (2016)

Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia
por: Upadhyay, Kirtikumar, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia
por: Sun, Huanxing, et al.
Publicado: (2013)

Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia
por: Jiménez, Julio, et al.
Publicado: (2016)

Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps
por: Chen, Cuie, et al.
Publicado: (2020)

Mitochondrial Fission-Mediated Lung Development in Newborn Rats With Hyperoxia-Induced Bronchopulmonary Dysplasia With Pulmonary Hypertension
por: Dai, Yuanyuan, et al.
Publicado: (2021)

CD8A is a Promising Biomarker Associated with Immunocytes Infiltration in Hyperoxia-Induced Bronchopulmonary Dysplasia
por: Du, Yiting, et al.
Publicado: (2023)

Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia
por: Lewis, T., et al.
Publicado: (2021)

SOX4 arrests lung development in rats with hyperoxia-induced bronchopulmonary dysplasia by controlling EZH2 expression
por: Pan, Bingting, et al.
Publicado: (2017)

Interleukin-33 (IL-33) Increases Hyperoxia-Induced Bronchopulmonary Dysplasia in Newborn Mice by Regulation of Inflammatory Mediators
por: Tang, Xiqin
Publicado: (2018)

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
por: Trittmann, J. K., et al.
Publicado: (2013)

Fetal haemoglobin and bronchopulmonary dysplasia in neonates: an observational study
por: Hellström, William, et al.
Publicado: (2021)

Serotonin‐deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension
por: Roberts, Danielle S., et al.
Publicado: (2022)

Hyperoxia induces endoplasmic reticulum stress-associated apoptosis via the IRE1α pathway in rats with bronchopulmonary dysplasia
por: Tong, Xin, et al.
Publicado: (2021)

Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia‐induced bronchopulmonary dysplasia in rats
por: Xie, Yingjun, et al.
Publicado: (2021)

ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis
por: Yang, Min, et al.
Publicado: (2023)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Turkish Neonatal Society guideline on prevention and management of bronchopulmonary dysplasia
por: Arsan, Saadet, et al.
Publicado: (2018)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Management of total intravenous anaesthesia in preterm neonates with bronchopulmonary dysplasia
por: Quintero, Carlos, et al.
Publicado: (2020)

Predictors of Bronchopulmonary Dysplasia in 625 Neonates with Respiratory Distress Syndrome
por: Tao, Yue, et al.
Publicado: (2022)

Progressive Metabolic Abnormalities Associated with the Development of Neonatal Bronchopulmonary Dysplasia
por: Ye, Chengyin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l346l896p9ls2t7t1ka8q3iom8